Nipent 2 mg/mL
PENTOSTATIN · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Hospira, Inc.
No Recall History
Plain English
Nipent is a injection, powder, lyophilized, for solution containing pentostatin at 2 mg/mL, taken intravenous. Manufactured by Hospira, Inc..
Key Facts
- Brand Name
- Nipent
- Generic Name
- PENTOSTATIN
- NDC Code (Product)
0409-0801- Manufacturer
- Hospira, Inc.
- Strength
- 2 mg/mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA020122
- Drug Class
- Nucleoside Metabolic Inhibitor [EPC]
- Marketing Start
- 08/15/2007
Recall History
No Recall HistoryFrequently Asked Questions
What is Nipent used for?
Nipent contains PENTOSTATIN. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Nipent a controlled substance?
Nipent is not classified as a controlled substance by the DEA.
What is the generic name for Nipent?
The generic name for Nipent is PENTOSTATIN. There are no other listed brand versions of PENTOSTATIN.
What is the NDC code for Nipent 2 mg/mL?
The NDC (National Drug Code) for Nipent 2 mg/mL is 0409-0801, listed by Hospira, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)